The Clorox Co. (CLX)

146.13
0.25 0.17
NYSE : Consumer Non-Durables
Prev Close 146.38
Open 146.37
Day Low/High 145.31 / 146.37
52 Wk Low/High 143.58 / 167.70
Volume 214.49K
Avg Volume 974.60K
Exchange NYSE
Shares Outstanding 125.50M
Market Cap 18.39B
EPS 6.40
P/E Ratio 23.29
Div & Yield 4.24 (2.77%)
Clorox Stock Becoming a Buy on Earnings Beat

Clorox Stock Becoming a Buy on Earnings Beat

Clorox stock is flying higher after beating second-quarter estimates. Could be time to buy it.

Clorox Tops Q2 Earnings Estimate, Confirms 2019 Outlook

Clorox Tops Q2 Earnings Estimate, Confirms 2019 Outlook

Clorox posted stronger-than-expected second quarter earnings Monday, and confirmed its full-year profit outlook but noted that trade tariffs will hit its bottom line.

What the Super Bowl Can Teach Us About Our Portfolio: Market Recon

What the Super Bowl Can Teach Us About Our Portfolio: Market Recon

And why maintaining a small position in defense stocks is important.

Google, Trump, General Motors, New England Patriots - 5 Things You Must Know

Google, Trump, General Motors, New England Patriots - 5 Things You Must Know

U.S. stock futures rise modestly as investors focus on stronger-than-expected jobs and manufacturing data from the United States last week; Google parent Alphabet reports earnings Monday after the closing bell; Donald Trump says there's a 'good chance' of a trade deal with China; the New England Patriots win their sixth Super Bowl title.

The Week Ahead: Alphabet, Disney and 12 Other Big Earnings Reports to Watch

The Week Ahead: Alphabet, Disney and 12 Other Big Earnings Reports to Watch

Buckle up after Super Sunday.

Bulls vs. Bears: Cramer's 'Mad Money' Recap (Friday 2/1/19)

Bulls vs. Bears: Cramer's 'Mad Money' Recap (Friday 2/1/19)

Jim Cramer makes sense of this market action and has your game plan for next week.

This Market's Holding Up: Cramer's 'Mad Money' Recap (Monday 1/28/19)

This Market's Holding Up: Cramer's 'Mad Money' Recap (Monday 1/28/19)

Jim Cramer takes a closer look at today's pin action, and talks about why the weakness didn't spread.

CVS Health, Neogenomics, Vicor: 'Mad Money' Lightning Round

CVS Health, Neogenomics, Vicor: 'Mad Money' Lightning Round

Jim Cramer weighs in on CVS Health, Neogenomics, Vicor, WD-40, T. Rowe Price, Clorox and more.

Let’s Talk About the Resistance Overhead Today

Because If we don’t we would be the only people NOT talking about it!

Keep an Eye on Earnings: Cramer's 'Mad Money' Recap (Thursday 1/3/19)

Keep an Eye on Earnings: Cramer's 'Mad Money' Recap (Thursday 1/3/19)

Jim Cramer says a trade deal could help, but what matters after today is earnings -- and how bad the shortfalls will be.

Jim Cramer: What Matters After Today Is Earnings

Jim Cramer: What Matters After Today Is Earnings

A trade deal with China could certainly help as well.

Jim Cramer: They Might Be Done

Jim Cramer: They Might Be Done

Whether this is the end of the slump is still up for debate, but the crash since October has been brutal and all bear markets end the same way.

Jim Cramer: Jay Powell Is a Nightmare for President Trump and Stock Buyers

Jim Cramer: Jay Powell Is a Nightmare for President Trump and Stock Buyers

5 key things investors need to know about their portfolios and how to proceed after the Fed's disappointing announcement.

Dividends and Diversification All in a Single ETF

NOBL is the only ETF that focuses exclusively on the Dividend Aristocrats.

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

Conflicting data about the economy should give the Federal Reserve pause.

Jim Cramer: We Can Play This Hot, Cold Game All Day Long

Jim Cramer: We Can Play This Hot, Cold Game All Day Long

There's enough evidence that the economy is slowing so the Fed shouldn't move on rates, but some big retail and unemployment numbers say the Fed must raise for certain.

The New #16 Most Shorted S&P 500 Component: Clorox

The New #16 Most Shorted S&P 500 Component: Clorox

The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Clorox Has Found Buyers in a Struggling Market

Clorox Has Found Buyers in a Struggling Market

The stock rocketed higher in November before pausing around Thanksgiving.

Playing the Trade-War Truce: Cramer's 'Mad Money' Recap (Monday 12/3/18)

Playing the Trade-War Truce: Cramer's 'Mad Money' Recap (Monday 12/3/18)

Jim Cramer looks at what companies are likely to benefit in the wake of President Trump's decision to hold off raising tariffs on Chinese goods.

Jim Cramer: Don't Throw Away These Stocks

Jim Cramer: Don't Throw Away These Stocks

It's done without much thought even though their companies are doing amazingly well.

Game Plan for Trade Talks: Cramer's 'Mad Money' Recap (Friday 11/30/18)

Game Plan for Trade Talks: Cramer's 'Mad Money' Recap (Friday 11/30/18)

Jim Cramer talks about how to play the outcome of tariff talks this weekend and position your portfolio ahead of next week's market reaction.

Jim Cramer: A Gameplan to Ride Out Trump-Jinping G-20 Talks

Jim Cramer: A Gameplan to Ride Out Trump-Jinping G-20 Talks

Here are some possible outcomes of this weekend, and how you can prepare your portfolio.

Clorox Shares Are Looking Still Brighter for the Months Ahead

Clorox Shares Are Looking Still Brighter for the Months Ahead

Let's check out the charts and indicators of CLX.

When Will the Pain End?: Cramer's 'Mad Money' Recap (Tuesday 11/27/18)

When Will the Pain End?: Cramer's 'Mad Money' Recap (Tuesday 11/27/18)

Jim Cramer says most - but not all - stocks are in a bear market. He talks about what's happening with Clorox, Coca-Cola, Verizon, Apple and more.

Jim Cramer: How Will We Know When the Pain Is Over?

Jim Cramer: How Will We Know When the Pain Is Over?

In a bear market the same pieces of news, perhaps weaker sales or perhaps tariffs, keep taking it down.

Jim Cramer Explains the Current State of the Economy

Jim Cramer Explains the Current State of the Economy

Jim Cramer gives his views on the current state of the economy.

Jim Cramer: Too Few Leaders, Too Many Clinkers

Jim Cramer: Too Few Leaders, Too Many Clinkers

It's awfully hard to tell what anyone is thinking or what patterns might exist that can be gamed and played.

Gridlock and Economic Slowing: Cramer's 'Mad Money' Recap (Tuesday 11/6/18)

Gridlock and Economic Slowing: Cramer's 'Mad Money' Recap (Tuesday 11/6/18)

Jim Cramer explains his post-election play book: Growth stocks may be the way to go.

Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow

Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow

Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!

Jim Cramer: Common Sense Is in Short Supply Right Now

Jim Cramer: Common Sense Is in Short Supply Right Now

It is time to address the issues that are really affecting business and get over the polarizing political battles.

TheStreet Quant Rating: B (Buy)